title: Lichenoid reaction induced by adalimumab.
authors.forename: C
authors.initials: C
authors.lastname: De Simone
authors.forename: G
authors.initials: G
authors.lastname: Caldarola
authors.forename: M
authors.initials: M
authors.lastname: D'Agostino
authors.forename: M
authors.initials: M
authors.lastname: Rotoli
authors.forename: R
authors.initials: R
authors.lastname: Capizzi
authors.forename: P
authors.initials: P
authors.lastname: Amerio
mesh_terms: D000068879:Adalimumab; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D015535:Arthritis, Psoriatic / Q000188:drug therapy; D006801:Humans; D017512:Lichenoid Eruptions / Q000139:chemically induced* / Q000175:diagnosis / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009061:Mouth Mucosa / Q000473:pathology
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D000068879:Adalimumab